StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$84.86−0.40 (-0.47%)

Close on Nov 17, 2026Market cap $21.32BP/E –Yield –

BioNTech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioNTech's price to sales ratio was 6.9× on Nov 11, 2026, against 7.8× a year earlier. Over the last 5 years it ranged from 1.1× to 117.4×, with a median of 6.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.9×−0.2
2025Dec 31, 20257.1×+0.2
2024Dec 31, 20246.9×+5.5
2023Dec 29, 20231.3×−0.5
2022Dec 30, 20221.8×−115.6
2021Dec 31, 2021117.4×−12.5
2020Dec 31, 2020129.8×+84.7
2019Dec 31, 201945.1×–

More BioNTech figures

See a number that looks wrong?